They are not bears. They are called “realists”.
jitin001
Posts
-
-
Wonder who are the people still buying $CVAC
-
Omg!!! Feed so sorry for the $CVAC hodlers. A similar fate awaits $NVAX despite their efficacy numbers. Too late to catch the train.
-
A bit confused about what $NVAX is reporting:
Total cases = 77
Placebo cases (ARU) = 63
Vaccine cases (ARV) = 14Vaccine efficiency (VE) = (ARU - ARV)/ ARU
So for $NVAX, VE = 77.77%
How did they arrive at 90+%??
https://wikimedia.org/api/rest_v1/media/math/render/svg/a59513ae1dc13906e69b48a02f9764db8a3966b4
-
Q: The most undervalued and under appreciated stock in the world?
A: $BNTX -
$BNTX - the most undervalued stock in the market today - is being held back by weak-hearted, “clay-handed” investors who simply don’t have enough belief to hold on to their shares despite all the fantastic news and great numbers being reported by the company. They keep selling, either taking profit on small upticks or panic-selling on the slightest negative news. If only $BNTX shareholders had “diamond-hands” like the punters driving $GME up for no rhyme or reason! Even the level of belief that $NVAX buyers are showing despite no actual vaccine being in the market would be sufficient to drive $BNTX to the moon. And there is simply no reason why $MRNA should have a market valuation that is 1.5x $BNTX. Parity with $MRNA itself should drive the price to $300+.
-
$BNTX is being held back by weak-hearted, “clay-handed” investors who simply don’t have enough belief to hold on to their shares despite all the fantastic news and great numbers being reported by the company. They keep selling, either taking profit on small upticks or panic-selling on the slightest negative news. If only $BNTX shareholders had “diamond-hands” like the punters driving $GME up for no rhyme or reason! Even the level of belief that $NVAX buyers are showing despite no actual vaccine being in the market would be sufficient to drive $BNTX to the moon. And there is simply no reason why $MRNA should have a market valuation that is 1.5x $BNTX. Parity with $MRNA itself should drive the price to $300+.
-
$BNTX is being held back by weak-hearted, “clay-handed” investors who simply don’t have enough belief to hold on to their shares despite all the fantastic news and great numbers being reported by the company. They keep selling, either taking profit on small upticks or panic-selling on the slightest negative news. If only $BNTX shareholders had “diamond-hands” like the punters driving $GME up for no rhyme or reason! Even the level of belief that $NVAX buyers are showing despite no actual vaccine being in the market would be sufficient to drive $BNTX to the moon. And there is simply no reason why $MRNA should have a market valuation that is 1.5x $BNTX. Parity with $MRNA itself should drive the price to $300+.
-
$BNTX is being held back by weak-hearted, “clay-handed” investors who simply don’t have enough belief to hold on to their shares despite all the fantastic news and great numbers being reported by the company. They keep selling, either taking profit on small upticks or panic-selling on the slightest negative news. If only $BNTX shareholders had “diamond-hands” like the punters driving $GME up for no rhyme or reason! Even the level of belief that $NVAX buyers are showing despite no actual vaccine being in the market would be sufficient to drive $BNTX to the moon. And there is simply no reason why $MRNA should have a market valuation that is 1.5x $BNTX. Parity with $MRNA itself should drive the price to $300+.
-
Stop selling, you idiots!
-
$BNTX is being held back by weak-hearted, “clay-handed” investors who simply don’t have enough belief to hold on to their shares despite all the fantastic news and great numbers being reported by the company. They keep selling, either taking profit on small upticks or panic-selling on the slightest negative news. If only $BNTX shareholders had “diamond-hands” like the punters driving $GME up for no rhyme or reason! Even the level of belief that $NVAX buyers are showing despite no actual vaccine being in the market would be sufficient to drive $BNTX to the moon. And there is simply no reason why $MRNA should have a market valuation that is 1.5x $BNTX. Parity with $MRNA itself should drive the price to $300+.
-
Still time to cut losses and buy $BNTX. The covid vaccine war is over and Pfizer/ BionTech have won it hands down, with Moderna taking the silver medal.
-
Still time to cut losses and buy $BNTX. The vaccine battle is over and Pfizer/ BionTech have won it hands down, with Moderna taking the silver medal.
-
It’s gonna be a bloodbath
-
$BNTX $MRNA $NVAX
And here’s data from Qatar. $BNTX is without doubt the best vaccine in the market, across all Covid variants:
https://www.washingtonpost.com/health/2021/05/05/pfizer-vaccine-virus-variants/ -
Meanwhile here’s some serious data from Israel:
https://www.independent.co.uk/news/health/pfizer-vaccine-coronavirus-israel-data-b1842617.html
-
Jamal your dumb strategy to dampen confidence is not working. All it is doing is making you look like the fucking moron that you are.
-
$BNTX
Av Est. EPS: $32.07 (‘21) and $18.69 (‘22)
Av Est. Revenue: $12.29B (‘21) and $7.73B (‘22)
Market Cap @ SP 180: $42.3B
P/E @ SP 180: 9.63 (based on ‘22 EPS)$MRNA
Av Est. EPS: $23.27 (‘21) and $16.58 (‘22)
Av Est. Revenue: $17.46B (‘21) and $13.69B (‘22)
Market Cap @ SP 180: $72.2B
P/E @ SP 180: 10.88 (based on ‘22 EPS)Looks like market is grossly underestimating revenue & EPS for $BNTX. Once revenue and EPS for this and next year for $BNTX becomes clear there will be a major price correction. If $BNTX has higher revenue and higher earnings it should have a higher market cap, so price should be more than 2x that of $MRNA.
CVAC
CVAC
CVAC
NVAX
BNTX
GME
CVAC
MRNA
NVAX
BNTX
BNTX
MRNA
OCGN
NVAX
NVAX
BNTX
BNTX
BNTX
BNTX
BNTX